Join to View Full Profile
111 S 11th StPhiladelphia, PA 19107
Phone+1 215-955-3158
Fax+1 215-955-9600
Dr. Sato is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Jichi Medical UniversityPh.D., Tumor Immunology, 1991
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHPost-Doctoral Fellowship, Hematology and Medical Oncology, 1997 - 2000- Sidney Kimmel Medical College at Thomas Jefferson UniversityResidency, Post-Doctral Fellow, 2000
Tokyo Medical and Dental UniversityClass of 1980
Certifications & Licensure
PA State Medical License 1992 - 2026
Japanese Society of PediatricsPediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014-2017
Clinical Trials
- Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors Start of enrollment: 2020 Feb 25
- Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma Start of enrollment: 2021 Jan 26
Publications & Presentations
PubMed
- Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025.Andrew E Aplin, Katherina Alsina, Allison S Betof, Joseph Birkett, Marcus O Butler
Pigment Cell & Melanoma Research. 2026-07-01 - Exceptional response of radiotherapy-naïve cranial meningiomas to dual immune checkpoint blockade in BAP1 tumor predisposition syndrome.Gary L Gallia, Christine L Hann, Calixto-Hope G Lucas, Licia Pacheco Luna, David O Kamson
Neuro-Oncology Advances. 2026-05-20 - Cancer Vaccine Targeting Mutated GNAQ-Expressing Uveal Melanoma.Vitali Alexeev, Mizue Terai, Sergei Koshkin, Olga Igoucheva, Takami Sato
Cancers. 2026-01-31
Press Mentions
Research Provides Clues to Improving CAR-T for Solid TumorsNovember 30th, 2021
Combination Treatments May Improve Survival for Patients with Metastatic Uveal MelanomaFebruary 6th, 2020
Shift in Treatment Modalities Associated with Improved Outcomes in Uveal Melanoma Patients with LiveFebruary 3rd, 2020
Professional Memberships
- Member
- Member
Other Languages
- Japanese
External Links
- TJUhttps://pulse.jefferson.edu/webapps/portal/frameset.jsp
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
